Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Completed 77Recruiting 12Unknown 11Active not recruiting 6Terminated 3Withdrawn 2Not yet recruiting 2

Sponsor Class

INDUSTRY 17OTHER 3UNKNOWN 1

Study Type

Interventional 2Observational 1

Sponsor

Conditions

Breast Neoplasms 723Neoplasms 461Prostatic Neoplasms 398Carcinoma, Non-Small-Cell Lung 388Lung Neoplasms 311Leukemia, Myeloid, Acute 301Multiple Myeloma 270Colorectal Neoplasms 243Neoplasm Metastasis 240Pancreatic Neoplasms 238Leukemia 235Melanoma 217Lymphoma 213Precursor Cell Lymphoblastic Leukemia-Lymphoma 204Brain Neoplasms 195Recurrence 178Head and Neck Neoplasms 177Lymphoma, Non-Hodgkin 174Myelodysplastic Syndromes 168Leukemia, Lymphocytic, Chronic, B-Cell 168Ovarian Neoplasms 160Carcinoma, Hepatocellular 154Glioblastoma 149Carcinoma, Renal Cell 137Rectal Neoplasms 134Colonic Neoplasms 129Lymphoma, Large B-Cell, Diffuse 125Lymphoma, Follicular 125Hodgkin Disease 116Squamous Cell Carcinoma of Head and Neck 109

Interventions

tilsotolimod 1Surveys and Questionnaires 1Nivolumab 1Ipilimumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Terminated × OTHER × Advanced Cancer × Clear all
NCT04270864 2024-10-18

PRIMO

Gustave Roussy, Cancer Campus, Grand Paris

Phase 1 Terminated
25 enrolled

Advanced Cancer

NCT05128539 2024-03-26

A Study Explore JS001+JS002 in Patients With Advanced Cancer

Shanghai Junshi Bioscience Co., Ltd.

Phase 1 Terminated
9 enrolled

Advanced Cancer

NCT00895024 2020-10-29

Caregiver Assessments of the Quality of Home Hospice Care

M.D. Anderson Cancer Center

Terminated
74 enrolled

Advanced Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡